Abiomed Inc ABMD:NASDAQ
Education help is ON
8.14 Arrow Down-0.41   -4.80% 220,960 Market data is delayed by at least 20 minutes.
Last Change  /  % Change Volume
Exclusive
Features
 
When you open a Scottrade account, you will be able to trade, add stocks to a watch list, set alerts and get real-time quotes. Or
 
1day |  5day |  6mo |  1yr |  5yr

Latest News Headlines for Abiomed Inc

Thursday 11/19/2009 10:21 PM ET - Comtex SmarTrend(R)

SmarTrend, our proprietary pattern recognition system, called a Downtrend for ABIOMED (NASDAQ:ABMD) on October 30, 2009 at $9.18.

Since then, ABIOMED has returned 7.2% as of today's recent price of $8.52. Want to profit from these alerts?

Thursday 11/12/2009 9:33 PM ET - Comtex SmarTrend(R)

SmarTrend, our proprietary pattern recognition system, called a Downtrend for ABIOMED (NASDAQ:ABMD) on October 30, 2009 at $9.18.

Since then, ABIOMED has returned 4% as of today's recent price of $8.81. Want to profit from these alerts?

Earlier Headlines - view recent headlines
--/--

Bid/Size

--/--

Ask/Size

8.51

Price Open

8.55

Previous Close

8.69

Day High

8.11

Day Low

0.91

Beta (5yr)

17.35/12/9/08

52wk High/Date

4.67/3/6/09

52wk Low/Date

305.1 Million

Market Capitalization

37.5 Million

Shares Outstanding

66.62

Volatility Avg (1 Year)

260.6 Thousand

Avg Vol (10 day)

NM

P/E Ratio

-0.84

EPS (TTM)

Abiomed Inc does not pay dividends.

Scottrade Customers

Get the following exclusive content at no additional cost with your Scottrade account:

  • Standard & Poor's STARS Rating for the featured stock
  • Research reports from Reuters and Standard & Poor's
  • Market Edge Second Opinion Weekly Report

For full analysis, Open an Account or Log In with Scottrade

Abiomed Inc vs. Peers

Company Market Cap YTD Price Performance
ABMD

Abiomed Inc

304.0M
-50.4%
TFX

Teleflex Incorporated

2.1B
+3.1%
THOR

Thoratec Corporation

1.7B
-10.6%
--

--

--
Scale is unavailable

Company Background

Abiomed Inc. is a provider of medical devices in circulatory support that offers a continuum of care in heart recovery to heart failure patients. The Company's products are designed to enable the heart to rest, heal and recover by improving blood flow and/or performing the pumping function of the heart. Its products can be used in a range of clinical settings, including by heart surgeons for patients in profound shock and by interventional cardiologists for patients who are in shock, pre-shock or in need of prophylactic support in the cardiac catheterization lab, or cath lab. Its circulatory care products are designed to provide hemodynamic support for acute patients from the cath lab to the surgery suite aimed towards heart recovery and sending the patient home with his or her native heart. The Company's cardiac assist products provide circulatory support to acute heart failure patients across the continuum of care in heart recovery.

© 2008 Scottrade

Brokerage Products and Services offered by Scottrade, Inc. - Member FINRA and SIPC

Online market and limit stock trades are just $7 for stocks priced $1 and above.

Any specific securities, or types of securities, used as examples are for demonstration purposes only. No information on this Web site should be considered a recommendation or None of the information provided should be considered a recommendation or solicitation to invest in, or liquidate, a particular security or type of security.

Investors should consider the investment objectives, risks, and charges and expenses of a mutual fund carefully before investing. A mutual fund's prospectus contains this and other information about the mutual fund. Prospectuses are available through our trading site or through a Scottrade branch office. The prospectus should be read carefully before investing. No transaction fee (NTF) funds are subject to the terms and conditions of the NTF funds program. Scottrade is compensated by the funds participating in the NTF program through recordkeeping, shareholder, or SEC 12b-1 fees.

Investors should consider the investment objectives, charges, expense, and unique risk profile of an Exchange Traded Fund (ETF) carefully before investing. Leveraged and Inverse ETFs may not be suitable for long-term investors and may increase exposure to volatility through the use of leverage, short sales of securities, derivatives and other complex investment strategies. A prospectus contains this and other information about the ETF and should be obtained from the issuer. The prospectus should be read carefully before investing.

Margin trading involves interest charges and risks, including the potential to lose more than deposited, or the need to deposit additional collateral in a falling market. Margin Disclosure Statement (PDF) is available for download, or it is available at one of our branch offices. It contains information on our lending policies, interest charges, and the risks associated with margin accounts.

Options involve risk and are not appropriate for all investors. Detailed information about the risks associated with options can be found in the Scottrade Options Application and Agreement, Brokerage Account Agreement, or by downloading the Characteristics and Risks of Standardized Options and Supplements (PDF) from The Options Clearing Corporation, or by requesting a copy from your local branch office. Supporting documentation for any claims will be supplied upon request.

Market volatility, volume, and system availability may impact account access and trade execution.

Testimonials may not be representative of the experience of other clients and are no guarantee of future performance or success.